Niagen Bioscience (NAGE)

• Market cap: $280M
• 1 day: 2.03%
• 5 days: 4.45%
• 1 month: -3.56%
• 3 months: -26.67%
• 6 months: -44.74%
• Year to date: -43.68%
• 1 year: -75.11%
• 5 years: -64.59%
• 10 years: -33.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117